|
|
||
|
Isolagen
Download PDF Members: Isolagen® Inc., a biotechnology company focused on developing emergent, novel skin and tissue rejuvenation technology for application in certain aesthetic and therapeutic markets. I am pleased to lead Isolagen Inc. as Chairman and Chief Executive Officer. Previously, I served as Chairman, President and CEO of Inamed Corporation, a leading specialty aesthetics company acquired by Allergan Inc. I joined Isolagen because I believe in the broad potential of the Isolagen Process™, a cutting-edge, innovative cellular processing system which produces the autologous living cell Isolagen Therapy™. I am committed to the science of cellular rejuvenation and to the development of new and novel therapies for aesthetic and therapeutic use. A broad clinical program for the Isolagen Therapy is advancing. In 2006, we reached agreement with the U.S. Food and Drug Administration (FDA), through the Special Protocol Assessment (SPA), on the study design of our Phase III pivotal trials to evaluate the efficacy and safety of Isolagen Therapy in treating nasolabial folds or wrinkles. We are excited to be on track with these studies, which are fully enrolled and underway. We are also preparing to move forward with a Phase II study of the Isolagen Therapy for full face rejuvenation. In addition to wrinkle correction, we are actively planning clinical trials in other aesthetic and therapeutic areas such as the treatment and prevention of burn scars (Phase II), treatment of acne scars (Phase II/III) and the treatment of dental papillary insufficiency or tissue loss associated with periodontal disease (Phase II). We are excited about the potential of our proprietary technology to treat these indications, as they represent large individual markets. We also market and sell an advanced skincare line through our majority-owned subsidiary, Agera Laboratories, Inc., which we acquired in 2006. Agera offers a complete line of skincare systems based on a wide array of proprietary formulations, trademarks and nano-peptide technology. These advanced skincare products offer anti-aging, anti-pigmentary and acne treatment systems which are marketed in both the United States and Europe. Nicholas L. Teti, Jr. Chairman and CEO Isolagen, Inc.
This page has been viewed 225 times since April 2007, the link to the organisation's website has been followed 43 times Recent Search Terms used to find this page: isolagen.com email | isolagen pdf | isolagen | isolagen | isolagen dental | isolagen patents | isolagen peptide | isolagen | . Search for more companies in Exton Search for more companies in PA This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Isolagen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
| Nothing in this website should be used in
place of personal medical advice from your own qualified medical
practitioner. |
All rights reserved. All other trademarks recognized. |
|
